U.S. Markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.20
    -0.16 (-0.31%)
     
  • Gold

    1,828.10
    -1.80 (-0.10%)
     
  • Silver

    24.87
    +0.00 (+0.02%)
     
  • EUR/USD

    1.2085
    -0.0079 (-0.6526%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • Vix

    24.34
    +1.09 (+4.69%)
     
  • GBP/USD

    1.3596
    -0.0044 (-0.3249%)
     
  • USD/JPY

    103.8370
    -0.0050 (-0.0048%)
     
  • BTC-USD

    36,220.75
    +1,220.09 (+3.49%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.12 (-0.62%)
     

New Strong Sell Stocks for December 18th

Zacks Equity Research
·1 min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Empire State Realty Trust, Inc. ESRT is a real estate investment trust  that owns, manages, operates, acquires and repositions office and retail properties. The Zacks Consensus Estimate for its current year earnings has been revised 5.3% downward over the last 30 days.

The RealReal, Inc. REAL operates an online marketplace for consigned luxury goods. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.

Applied DNA Sciences, Inc. APDN engages in polymerase chain reaction-based DNA manufacturing. The Zacks Consensus Estimate for its current year earnings has been revised 2% downward over the last 30 days.

X4 Pharmaceuticals, Inc. XFOR is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of novel therapeutics for the treatment of primary immune-deficiencies and cancer. The Zacks Consensus Estimate for its current year earnings has been revised 8.6% downward over the last 60 days.

SharpSpring, Inc. SHSP operates as a cloud-based marketing technology company. The Zacks Consensus Estimate for its current year earnings has been revised 78.6% downward over the last 60 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Applied DNA Sciences Inc (APDN) : Free Stock Analysis Report
 
Empire State Realty Trust, Inc. (ESRT) : Free Stock Analysis Report
 
SharpSpring, Inc. (SHSP) : Free Stock Analysis Report
 
X4 Pharmaceuticals, Inc. (XFOR) : Free Stock Analysis Report
 
The RealReal, Inc. (REAL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research